Debt-to-equity of REGENERON PHARMACEUTICALS, INC. from 31 Mar 2011 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
REGENERON PHARMACEUTICALS, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2011 to 31 Dec 2025.
  • REGENERON PHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 31 Dec 2025 was 29%, a 3% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

REGENERON PHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 29% +0.85% +3% 31 Dec 2025
Q3 2025 28% +0.88% +3.2% 30 Sep 2025
Q2 2025 28% 0% +0.01% 30 Jun 2025
Q1 2025 28% +0.14% +0.52% 31 Mar 2025
Q4 2024 28% -0.11% -0.4% 31 Dec 2024
Q3 2024 28% -0.82% -2.9% 30 Sep 2024
Q2 2024 28% -0.44% -1.6% 30 Jun 2024
Q1 2024 28% -1.4% -4.9% 31 Mar 2024
Q4 2023 28% -2.4% -7.8% 31 Dec 2023
Q3 2023 28% -3.6% -11% 30 Sep 2023
Q2 2023 28% -5.6% -16% 30 Jun 2023
Q1 2023 29% -7.1% -20% 31 Mar 2023
Q4 2022 30% -9.6% -24% 31 Dec 2022
Q3 2022 32% -13% -28% 30 Sep 2022
Q2 2022 34% -16% -32% 30 Jun 2022
Q1 2022 36% -19% -34% 31 Mar 2022
Q4 2021 40% -9.8% -20% 31 Dec 2021
Q3 2021 45% +0.58% +1.3% 30 Sep 2021
Q2 2021 50% +13% +33% 30 Jun 2021
Q1 2021 55% +23% +69% 31 Mar 2021
Q4 2020 50% +16% +45% 31 Dec 2020
Q3 2020 44% +9.6% +28% 30 Sep 2020
Q2 2020 38% +2.2% +6.1% 30 Jun 2020
Q1 2020 33% -3.7% -10% 31 Mar 2020
Q4 2019 34% -3.5% -9.4% 31 Dec 2019
Q3 2019 34% -5.6% -14% 30 Sep 2019
Q2 2019 36% -6.2% -15% 30 Jun 2019
Q1 2019 36% -7.6% -17% 31 Mar 2019
Q4 2018 38% -10% -21% 31 Dec 2018
Q3 2018 40% -11% -22% 30 Sep 2018
Q2 2018 42% -12% -22% 30 Jun 2018
Q1 2018 44% -12% -21% 31 Mar 2018
Q4 2017 48% -6.5% -12% 31 Dec 2017
Q3 2017 51% -2.3% -4.2% 30 Sep 2017
Q2 2017 54% -1% -1.8% 30 Jun 2017
Q1 2017 56% +4.6% +9% 31 Mar 2017
Q4 2016 54% +7.2% +15% 31 Dec 2016
Q3 2016 54% +7.6% +16% 30 Sep 2016
Q2 2016 55% +12% +28% 30 Jun 2016
Q1 2016 51% +5.1% +11% 31 Mar 2016
Q4 2015 47% -0.45% -0.95% 31 Dec 2015
Q3 2015 46% -1.6% -3.3% 30 Sep 2015
Q2 2015 43% -6.8% -14% 30 Jun 2015
Q1 2015 46% -6.9% -13% 31 Mar 2015
Q4 2014 48% -8.9% -16% 31 Dec 2014
Q3 2014 48% -13% -22% 30 Sep 2014
Q2 2014 50% -20% -29% 30 Jun 2014
Q1 2014 53% -31% -37% 31 Mar 2014
Q4 2013 57% -73% -56% 31 Dec 2013
Q3 2013 61% -123% -67% 30 Sep 2013
Q2 2013 69% -140% -67% 30 Jun 2013
Q1 2013 84% -122% -59% 31 Mar 2013
Q4 2012 129% -2.4% -1.8% 31 Dec 2012
Q3 2012 183% +68% +60% 30 Sep 2012
Q2 2012 210% +88% +72% 30 Jun 2012
Q1 2012 206% +86% +71% 31 Mar 2012
Q4 2011 132% 31 Dec 2011
Q3 2011 115% 30 Sep 2011
Q2 2011 122% 30 Jun 2011
Q1 2011 121% 31 Mar 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.